TSPO and central nervous system cancer: TSPO deficiency causes an imbalance in mitochondrial metabolic function, decreased oxidative phosphorylation and ATP production, increased intracellular ROS levels, and a shift in cellular metabolism from oxidative phosphorylation to the glycolytic pathway, resulting in increased angiogenesis, glioma growth, and increased malignancy [21].